Ionis Pharmaceuticals, Inc. (IONS)
27.31
-1.02
(-3.60%)
USD |
NASDAQ |
Nov 12, 16:00
27.50
+0.19
(+0.70%)
After-Hours: 05:32
Ionis Pharmaceuticals Free Cash Flow (Quarterly) : -193.63M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -193.63M |
| June 30, 2026 | 547.30M |
| March 31, 2026 | -816.07M |
| December 31, 2025 | -160.37M |
| September 30, 2025 | -138.37M |
| June 30, 2025 | 137.07M |
| March 31, 2025 | -164.00M |
| December 31, 2024 | -144.18M |
| September 30, 2024 | -111.30M |
| June 30, 2024 | -140.14M |
| March 31, 2024 | -155.67M |
| December 31, 2023 | 32.89M |
| September 30, 2023 | -112.26M |
| June 30, 2023 | -110.44M |
| March 31, 2023 | -145.72M |
| December 31, 2022 | -205.20M |
| September 30, 2022 | -31.49M |
| June 30, 2022 | -22.60M |
| March 31, 2022 | -35.18M |
| December 31, 2021 | 199.70M |
| September 30, 2021 | -60.17M |
| June 30, 2021 | -68.96M |
| March 31, 2021 | -57.66M |
| December 31, 2020 | 91.10M |
| September 30, 2020 | -23.25M |
| Date | Value |
|---|---|
| June 30, 2020 | -55.44M |
| March 31, 2020 | -17.58M |
| December 31, 2019 | 274.37M |
| September 30, 2019 | -30.59M |
| June 30, 2019 | -32.40M |
| March 31, 2019 | 103.44M |
| December 31, 2018 | 113.38M |
| September 30, 2018 | -30.71M |
| June 30, 2018 | 492.49M |
| March 31, 2018 | 10.08M |
| December 31, 2017 | 13.34M |
| September 30, 2017 | 8.975M |
| June 30, 2017 | -4.463M |
| March 31, 2017 | 118.44M |
| December 31, 2016 | -29.80M |
| September 30, 2016 | 21.18M |
| June 30, 2016 | -38.23M |
| March 31, 2016 | -76.78M |
| December 31, 2015 | -40.61M |
| September 30, 2015 | 36.63M |
| June 30, 2015 | 60.40M |
| March 31, 2015 | -44.42M |
| December 31, 2014 | 65.99M |
| September 30, 2014 | 0.423M |
| June 30, 2014 | -37.17M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 271.15M |
| BridgeBio Pharma, Inc. | -44.46M |
| Biogen, Inc. | 375.40M |
| Ultragenyx Pharmaceutical, Inc. | -45.00M |
| Krystal Biotech, Inc. | 90.25M |